Global Metformin Hydrochloride Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Metformin Hydrochloride market size was valued at US$ 423 million in 2024 and is forecast to a readjusted size of USD 605 million by 2031 with a CAGR of 5.3% during review period.
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.
The global key manufacturers of Metformin Hydrochloride include Keyuan Pharmaceutical, Aarti Drugs and Shijiazhuang Polee, etc, top 3 manufacturers hold a share approximately 36%. Keyuan Pharmaceutical is the world's largest Metformin Hydrochloride manufacturer, with a market share of more than 14%. India, China and Europe are the major Metformin Hydrochloride market, they have a market share of more than 68%. India is the largest market with a share of 46%. In terms of product type, Metformin HCL is the largest market segment with a share of more than 82%. In terms of applications, Metformin Hydrochloride Tablets is the largest downstream segment, with a market share of about 72%.
This report is a detailed and comprehensive analysis for global Metformin Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Metformin Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2020-2031
Global Metformin Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2020-2031
Global Metformin Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2020-2031
Global Metformin Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Metformin Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Metformin Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane, Keyuan Pharmaceutical, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Aarti Drugs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Metformin Hydrochloride market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Metformin HCL
Metformin DC
Market segment by Application
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others
Major players covered
Wanbury
USV
Shouguang Fukang Pharmaceutical
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Aarti Drugs
Exemed Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metformin Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Metformin Hydrochloride, with price, sales quantity, revenue, and global market share of Metformin Hydrochloride from 2020 to 2025.
Chapter 3, the Metformin Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metformin Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Metformin Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Metformin Hydrochloride.
Chapter 14 and 15, to describe Metformin Hydrochloride sales channel, distributors, customers, research findings and conclusion.
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform. In this report, our statistics is given by metformin hydrochloride API.
The global key manufacturers of Metformin Hydrochloride include Keyuan Pharmaceutical, Aarti Drugs and Shijiazhuang Polee, etc, top 3 manufacturers hold a share approximately 36%. Keyuan Pharmaceutical is the world's largest Metformin Hydrochloride manufacturer, with a market share of more than 14%. India, China and Europe are the major Metformin Hydrochloride market, they have a market share of more than 68%. India is the largest market with a share of 46%. In terms of product type, Metformin HCL is the largest market segment with a share of more than 82%. In terms of applications, Metformin Hydrochloride Tablets is the largest downstream segment, with a market share of about 72%.
This report is a detailed and comprehensive analysis for global Metformin Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Metformin Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2020-2031
Global Metformin Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2020-2031
Global Metformin Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/MT), 2020-2031
Global Metformin Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Metformin Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Metformin Hydrochloride market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane, Keyuan Pharmaceutical, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Aarti Drugs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Metformin Hydrochloride market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Metformin HCL
Metformin DC
Market segment by Application
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others
Major players covered
Wanbury
USV
Shouguang Fukang Pharmaceutical
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Aarti Drugs
Exemed Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metformin Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Metformin Hydrochloride, with price, sales quantity, revenue, and global market share of Metformin Hydrochloride from 2020 to 2025.
Chapter 3, the Metformin Hydrochloride competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metformin Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Metformin Hydrochloride market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Metformin Hydrochloride.
Chapter 14 and 15, to describe Metformin Hydrochloride sales channel, distributors, customers, research findings and conclusion.
Table of Contents
123 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Metformin Hydrochloride by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
